Pfizer plans to test a third dose of its COVID vaccine on infants and young children

Posted by on December 17, 2021 1:32 pm
Categories: US National Stories

An information sign is displayed as a child arrives with her parent to receive the Pfizer COVID-19 vaccine for children 5 to 11-years-old at London Middle School in Wheeling, Ill., last month.

Pfizer and BioNTech, which produced the first COVID-19 vaccine authorized in the U.S., say they will expand ongoing trials to include a third dose for children as young as 6 months old.

(Image credit: Nam Y. Huh/AP)

Leave a Reply

Your email address will not be published.